electroCore reiterates FY 2026 revenue guidance

electroCore,.

06/05/2026 21:40

Overview

Bioelectronic technology firm's Q1 revenue rose 43%, beating analyst expectations

Q1 operating income and pretax profit both missed analyst estimates

Adjusted EBITDA net loss improved 24% yr/yr as platform scales

Outlook

electroCore reiterates full-year 2026 revenue guidance of approximately 30% annual growth over 2025

Company expects majority of 2026 revenue to continue coming from the VA channel

electroCore plans to launch Quell Relief for lower extremity pain in H2 2026

Result Drivers

VA PRESCRIPTION SALES - Growth in prescription gammaCore sales to the U.S. Department of Veterans Affairs was the company's largest revenue driver

TRUVAGA EXPANSION - Truvaga revenue grew 38% year-over-year, supported by improved marketing efficiency and international launch in the UK

QUELL FRANCHISE CONTRIBUTION - Sales of Quell Fibromyalgia products, acquired from NeuroMetrix in 2025 and sold to the VA, contributed meaningfully to revenue

Company press release: ID:nGNX2bmzhQ

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$9.58 mln
$9.01 mln (5 Analysts)
Q1 Net Income
-$5.27 mln
Q1 Operating Income
Miss
-$5.32 mln
-$4.55 mln (3 Analysts)
Q1 Pretax Profit
Miss
-$5.59 mln
-$4.34 mln (4 Analysts)
Q1 Gross Profit
$8.36 mln
Q1 Operating Expenses
$13.68 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for electroCore, Inc. is $22.00, about 214.7% above its May 5 closing price of $6.99

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)